Physiological significance of delayed rectifier K+ channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease

Cahalan MD, Chandy KG, DeCoursey TE, Gupta S (1985) A voltage-gated potassium channel in human T lymphocytes. J Physiol 358:197–237 DeCoursey TE, Chandy KG, Gupta S, Cahalan MD (1984) Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature 307:465–468 Lewis RS, Cahalan MD (1995) Potassium and calcium channels in lymphocytes. Annu Rev Immunol 13:623–653 Ishida Y, Chused TM (1993) Lack of voltage sensitive potassium channels and generation of membrane potential by sodium potassium ATPase in murine T lymphocytes. J Immunol 151:610–620 Deutsch C, Chen LQ (1993) Heterologous expression of specific K+ channels in T lymphocytes: functional consequences for volume regulation. Proc Natl Acad Sci USA 90:10036–10040 Cahalan MD, Wulff H, Chandy KG (2001) Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol 21:235–252 Hu L, Pennington M, Jiang Q, Whartenby KA, Calabresi PA (2007) Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes. J Immunol 179:4563–4570 Chandy KG, Wulff H, Beeton C, Pennington M, Gutman GA et al (2004) K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci 25:280–289 Sugiyama K, Isogai K, Toyama A, Satoh H, Saito K et al (2011) Correlation between the pharmacological efficacy of cyclosporine and tacrolimus as evaluated by the lymphocyte immunosuppressant sensitivity test (LIST) and the MTT assay procedure in patients before and after renal transplantation. Int J Clin Pharmacol Ther 49:145–152 Rangaraju S, Chi V, Pennington MW, Chandy KG (2009) Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opin Ther Targets 13:909–924 Cho JY (2007) Immunomodulatory effect of nonsteroidal anti-inflammatory drugs (NSAIDs) at the clinically available doses. Arch Pharm Res 30:64–74 Sugiyama K, Shirai R, Mukae H, Ishimoto H, Nagata T et al (2007) Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. Clin Exp Immunol 147:540–546 Morikawa K, Zhang J, Nonaka M, Morikawa S (2002) Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production. Int J Antimicrob Agents 19:53–59 Khan AA, Slifer TR, Araujo FG, Remington JS (1999) Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int J Antimicrob Agents 11:121–132 Palamaras I, Kyriakis K (2005) Calcium antagonists in dermatology: a review of the evidence and research-based studies. Dermatol Online J 11:8 Horvath M, Mezey Z, Josfay A, Nanay I, Varsanyi M et al (1991) The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction. J Investig Allergol Clin Immunol 1:404–410 Zhou Y, Hancock JF, Lichtenberger LM (2010) The nonsteroidal anti-inflammatory drug indomethacin induces heterogeneity in lipid membranes: potential implication for its diverse biological action. PLoS One 5:e8811 Zuckerman JM (2004) Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Infect Dis Clin N Am 18:621–649, xi. Chester DW, Herbette LG, Mason RP, Joslyn AF, Triggle DJ et al (1987) Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers. Biophys J 52:1021–1030 Young HS, Skita V, Mason RP, Herbette LG (1992) Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism. Biophys J 61:1244–1255 Heap GA, van Heel DA (2009) The genetics of chronic inflammatory diseases. Hum Mol Genet 18:R101–R106 Kazama I, Maruyama Y, Baba A (2014) Amphipath-induced plasma membrane curvature controls microparticle formation from adipocytes: novel therapeutic implications for metabolic disorders. Med Hypotheses 82:196–198 Bohle A, Strutz F, Muller GA (1994) On the pathogenesis of chronic renal failure in primary glomerulopathies: a view from the interstitium. Exp Nephrol 2:205–210 Strutz F, Zeisberg M (2006) Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 17:2992–2998 Michimata M, Kazama I, Mizukami K, Araki T, Nakamura Y et al (2003) Urinary concentration defect and limited expression of sodium cotransporter, rBSC1, in a rat model of chronic renal failure. Nephron Physiol 93:34–41 Suzuki K, Hatano R, Michimata M, Kazama I, Suzuki M et al (2005) Residual urinary concentrating ability and AQP2 expression in a rat model for chronic renal failure. Nephron Physiol 99:16–22 Sanada S, Toyama H, Ejima Y, Matsubara M (2009) Potential for erythropoietin synthesis in kidney of uraemic rat alters depending on severity of renal failure. Nephrology (Carlton) 14:735–742 Kumano K, Kogure K, Tanaka T, Sakai T (1986) A new method of inducing experimental chronic renal failure by cryosurgery. Kidney Int 30:433–436 Jones SE, Kelly DJ, Cox AJ, Zhang Y, Gow RM et al (2003) Mast cell infiltration and chemokine expression in progressive renal disease. Kidney Int 64:906–913 Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G (2005) Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68:237–245 Chatenoud L, Dugas B, Beaurain G, Touam M, Drueke T et al (1986) Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity. Proc Natl Acad Sci USA 83:7457–7461 Kaysen GA, Kumar V (2003) Inflammation in ESRD: causes and potential consequences. J Ren Nutr 13:158–160 Barreto DV, Barreto FC, Liabeuf S, Temmar M, Lemke HD et al (2010) Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int 77:550–556 Cahalan MD, Chandy KG (2009) The functional network of ion channels in T lymphocytes. Immunol Rev 231:59–87 Grissmer S, Dethlefs B, Wasmuth JJ, Goldin AL, Gutman GA et al (1990) Expression and chromosomal localization of a lymphocyte K+ channel gene. Proc Natl Acad Sci USA 87:9411–9415 Grissmer S, Nguyen AN, Cahalan MD (1993) Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology. J Gen Physiol 102:601–630 Lewis RS, Cahalan MD (1989) Mitogen-induced oscillations of cytosolic Ca2+ and transmembrane Ca2+ current in human leukemic T cells. Cell Regul 1:99–112 Lewis RS, Ross PE, Cahalan MD (1993) Chloride channels activated by osmotic stress in T lymphocytes. J Gen Physiol 101:801–826 Kozak JA, Matsushita M, Nairn AC, Cahalan MD (2005) Charge screening by internal pH and polyvalent cations as a mechanism for activation, inhibition, and rundown of TRPM7/MIC channels. J Gen Physiol 126:499–514 Kazama I, Maruyama Y, Murata Y, Sano M (2012) Voltage-dependent biphasic effects of chloroquine on delayed rectifier K(+)-channel currents in murine thymocytes. J Physiol Sci 62:267–274 Kazama I, Maruyama Y, Murata Y (2012) Suppressive effects of nonsteroidal anti-inflammatory drugs diclofenac sodium, salicylate and indomethacin on delayed rectifier K+-channel currents in murine thymocytes. Immunopharmacol Immunotoxicol 34:874–878 Kazama I, Maruyama Y (2013) Differential effects of clarithromycin and azithromycin on delayed rectifier K(+)-channel currents in murine thymocytes. Pharm Biol 51:760–765 Kazama I, Maruyama Y, Matsubara M (2013) Benidipine persistently inhibits delayed rectifier K(+)-channel currents in murine thymocytes. Immunopharmacol Immunotoxicol 35:28–33 Hamilton DL, Beall C, Jeromson S, Chevtzoff C, Cuthbertson DJ et al (2014) Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle. J Physiol Sci 64:13–20 Han S, Yi H, Yin SJ, Chen ZY, Liu H et al (2008) Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease. J Biol Chem 283:19058–19065 Chandy KG, Cahalan M, Pennington M, Norton RS, Wulff H et al (2001) Potassium channels in T lymphocytes: toxins to therapeutic immunosuppressants. Toxicon 39:1269–1276 Mouhat S, Teodorescu G, Homerick D, Visan V, Wulff H et al (2006) Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain. Mol Pharmacol 69:354–362 Orban C, Biro E, Grozdics E, Bajnok A, Toldi G (2013) Modulation of T lymphocyte calcium influx patterns via the inhibition of kv1.3 and ikca1 potassium channels in autoimmune disorders. Front Immunol 4:234 Beeton C, Wulff H, Barbaria J, Clot-Faybesse O, Pennington M et al (2001) Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci USA 98:13942–13947 Gotzsche PC (1989) Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Control Clin Trials 10:31–56 Wallace DJ (2010) Advances in drug therapy for systemic lupus erythematosus. BMC Med 8:77 Kazama I, Sasagawa N, Nakajima T (2012) Complete remission of human parvovirus b19 associated symptoms by loxoprofen in patients with atopic predispositions. Case Rep Med 2012:703281 Iniguez MA, Punzon C, Fresno M (1999) Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J Immunol 163:111–119 Hackstein H, Morelli AE, Larregina AT, Ganster RW, Papworth GD et al (2001) Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol 166:7053–7062 Gao JX, Issekutz AC (1993) The effect of ebselen on polymorphonuclear leukocyte migration to joints in rats with adjuvant arthritis. Int J Immunopharmacol 15:793–802 Villalonga N, David M, Bielanska J, Gonzalez T, Parra D et al (2010) Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels. Biochem Pharmacol 80:858–866 Mazzei T, Mini E, Novelli A, Periti P (1993) Chemistry and mode of action of macrolides. J Antimicrob Chemother 31(Suppl C):1–9 Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M (1998) Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157:1829–1832 Kanoh S, Rubin BK (2010) Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 23:590–615 Price M, Lee SC, Deutsch C (1989) Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes. Proc Natl Acad Sci USA 86:10171–10175 Braunwald E (1982) Mechanism of action of calcium-channel-blocking agents. N Engl J Med 307:1618–1627 Birx DL, Berger M, Fleisher TA (1984) The interference of T cell activation by calcium channel blocking agents. J Immunol 133:2904–2909 Bacon KB, Westwick J, Camp RD (1989) Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists. Biochem Biophys Res Commun 165:349–354 Matsumori A, Nishio R, Nose Y (2010) Calcium channel blockers differentially modulate cytokine production by peripheral blood mononuclear cells. Circ J 74:567–571 Liu W, Matsumori A (2011) Calcium channel blockers and modulation of innate immunity. Curr Opin Infect Dis 24:254–258 Gluais P, Bastide M, Grandmougin D, Fayad G, Adamantidis M (2003) Clarithromycin reduces Isus and Ito currents in human atrial myocytes with minor repercussions on action potential duration. Fundam Clin Pharmacol 17:691–701 Volberg WA, Koci BJ, Su W, Lin J, Zhou J (2002) Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 302:320–327 Kalman K, Pennington MW, Lanigan MD, Nguyen A, Rauer H et al (1998) ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide. J Biol Chem 273:32697–32707 Furukawa T, Yamakawa T, Midera T, Sagawa T, Mori Y et al (1999) Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes. J Pharmacol Exp Ther 291:464–473 Herbette LG, Chester DW, Rhodes DG (1986) Structural analysis of drug molecules in biological membranes. Biophys J 49:91–94 Kitakaze M, Node K, Minamino T, Asanuma H, Kuzuya T et al (1999) A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs. J Am Coll Cardiol 33:242–249 Yamamoto M, Gotoh Y, Imaizumi Y, Watanabe M (1990) Mechanisms of long-lasting effects of benidipine on Ca current in guinea-pig ventricular cells. Br J Pharmacol 100:669–676 Vater W, Kroneberg G, Hoffmeister F, Saller H, Meng K et al (1972) Pharmacology of 4-(2′-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040). Arzneimittelforschung 22:1–14 Karasawa A, Kubo K (1988) Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries. Jpn J Pharmacol 47:35–44 Robe RJ, Grissmer S (2000) Block of the lymphocyte K(+) channel mKv1.3 by the phenylalkylamine verapamil: kinetic aspects of block and disruption of accumulation of block by a single point mutation. Br J Pharmacol 131:1275–1284 Rauer H, Grissmer S (1999) The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel. Br J Pharmacol 127:1065–1074 DeCoursey TE (1995) Mechanism of K+ channel block by verapamil and related compounds in rat alveolar epithelial cells. J Gen Physiol 106:745–779 Yellen G (1998) The moving parts of voltage-gated ion channels. Q Rev Biophys 31:239–295 Kazama I, Maruyama Y, Takahashi S, Kokumai T (2013) Amphipaths differentially modulate membrane surface deformation in rat peritoneal mast cells during exocytosis. Cell Physiol Biochem 31:592–600 Neher E, Marty A (1982) Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells. Proc Natl Acad Sci USA 79:6712–6716 Kazama I, Maruyama Y, Nakamichi S (2014) Aspirin-induced microscopic surface changes stimulate thrombopoiesis in rat megakaryocytes. Clin Appl Thromb Hemost 20:318–325 Kazama I, Endo Y, Toyama H, Ejima Y, Kurosawa S et al (2011) Compensatory thrombopoietin production from the liver and bone marrow stimulates thrombopoiesis of living rat megakaryocytes in chronic renal failure. Nephron Extra 1:147–156 Mahaut-Smith MP, Thomas D, Higham AB, Usher-Smith JA, Hussain JF et al (2003) Properties of the demarcation membrane system in living rat megakaryocytes. Biophys J 84:2646–2654 Fisher JL, Levitan I, Margulies SS (2004) Plasma membrane surface increases with tonic stretch of alveolar epithelial cells. Am J Respir Cell Mol Biol 31:200–208 Morris CE, Homann U (2001) Cell surface area regulation and membrane tension. J Membr Biol 179:79–102 Suzuki K, Imada T, Gao F, Ma H, Nagata T (1994) Radioautographic study of benidipine hydrochloride. Localization in the mesenteric artery of spontaneously hypertensive rat. Arzneimittelforschung 44:129–133 Teisseyre A, Zmonarski SC, Klinger M, Mozrzymas JW, Miekisz S (1996) Patch-clamp study on T-lymphocyte potassium conductance in patients with chronic renal failure. Nephron 72:587–594 Grgic I, Wulff H, Eichler I, Flothmann C, Kohler R et al (2009) Blockade of T-lymphocyte KCa3.1 and Kv1.3 channels as novel immunosuppression strategy to prevent kidney allograft rejection. Transplant Proc 41:2601–2606 Hyodo T, Oda T, Kikuchi Y, Higashi K, Kushiyama T et al (2010) Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis. Am J Physiol Renal Physiol 299:F1258–F1269 Platt R, Roscoe MH, Smith FW (1952) Experimental renal failure. Clin Sci (Lond) 11:217–231 Morrison AB (1962) Experimentally induced chronic renal insufficiency in the rat. Lab Investig 11:321–332 Avioli LV, Scott S, Lee SW, De Luca HF (1969) Intestinal calcium absorption: nature of defect in chronic renal disease. Science 166:1154–1156 Bencosme SA, Stone RS, Latta H, Madden SC (1960) Acute tubular and glomerular lesions in rat kidneys after uranium injury. Arch Pathol 69:470–476 Fukuda S, Kopple JD (1980) Chronic uremia syndrome in dogs induced with uranyl nitrate. Nephron 25:139–143 Allison ME, Wilson CB, Gottschalk CW (1974) Pathophysiology of experimental glomerulonephritis in rats. J Clin Investig 53:1402–1423 Kondo Y, Shigematsu H, Kobayashi Y (1972) Cellular aspects of rabbit Masugi nephritis. II. Progressive glomerular injuries with crescent formation. Lab Investig 27:620–631 Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM (1981) Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241:F85–F93 Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652–659 Kohzuki M, Kanazawa M, Liu PF, Kamimoto M, Yoshida K et al (1995) Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors. J Hypertens 13:1785–1790 Kazama I, Maruyama Y, Endo Y, Toyama H, Ejima Y et al (2012) Overexpression of delayed rectifier K(+) channels promotes in situ proliferation of leukocytes in rat kidneys with advanced chronic renal failure. Int J Nephrol 2012:581581 El Nahas AM, Anderson S, Harris KPG (eds) (2000) Mechanisms and management of progressive renal failure. Oxford University Press, London, pp 104–145 Litjens NH, van Druningen CJ, Betjes MG (2006) Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol 118:83–91 Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC (1995) Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. Kidney Int 48:753–760 Escobar LI, Martinez-Tellez JC, Salas M, Castilla SA, Carrisoza R et al (2004) A voltage-gated K(+) current in renal inner medullary collecting duct cells. Am J Physiol Cell Physiol 286:C965–C974 Abdul M, Hoosein N (2002) Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett 186:99–105 Jang SH, Kang KS, Ryu PD, Lee SY (2009) Kv1.3 voltage-gated K(+) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Rep 42:535–539 Huang S, Zhang CT, Tang JR, Tang J, Cai L, Zhang Z, Zhou MG (2010) Upregulated voltage-gated potassium channel Kv1.3 on CD4+CD28null T lymphocytes from patients with acute coronary syndrome. J Geriatr Cardiol 7:40–46 Toldi G, Bajnok A, Dobi D, Kaposi A, Kovacs L et al (2013) The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis. Immunobiology 218:311–316 Rus H, Pardo CA, Hu L, Darrah E, Cudrici C et al (2005) The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci USA 102:11094–11099 Schilling T, Eder C (2003) Effects of kinase inhibitors on TGF-beta induced upregulation of Kv1.3 K+ channels in brain macrophages. Pflugers Arch 447:312–315 Miyazaki T, Ise M, Seo H, Niwa T (1997) Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys. Kidney Int Suppl 62:S15–S22 Wonderlin WF, Strobl JS (1996) Potassium channels, proliferation and G1 progression. J Membr Biol 154:91–107 Jang SH, Choi SY, Ryu PD, Lee SY (2011) Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. Eur J Pharmacol 651:26–32 Lewis RJ, Garcia ML (2003) Therapeutic potential of venom peptides. Nat Rev Drug Discov 2:790–802 Judge SI, Lee JM, Bever CT Jr, Hoffman PM (2006) Voltage-gated potassium channels in multiple sclerosis: overview and new implications for treatment of central nervous system inflammation and degeneration. J Rehabil Res Dev 43:111–122 Grgic I, Kiss E, Kaistha BP, Busch C, Kloss M et al (2009) Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc Natl Acad Sci USA 106:14518–14523 Kazama I, Baba A, Maruyama Y (2014) HMG-CoA reductase inhibitors pravastatin, lovastatin and simvastatin suppress delayed rectifier K(+)-channel currents in murine thymocytes. Pharmacol Rep 66:712–717 Schmitz A, Sankaranarayanan A, Azam P, Schmidt-Lassen K, Homerick D et al (2005) Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol Pharmacol 68:1254–1270 McCloskey C, Jones S, Amisten S, Snowden RT, Kaczmarek LK et al (2010) Kv1.3 is the exclusive voltage-gated K+ channel of platelets and megakaryocytes: roles in membrane potential, Ca2+ signalling and platelet count. J Physiol 588:1399–1406